"Sarcomeres" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The repeating contractile units of the MYOFIBRIL, delimited by Z bands along its length.
Descriptor ID |
D012518
|
MeSH Number(s) |
A10.690.552.875.700 A11.284.430.214.190.875.820 A11.620.249.850.700 A11.620.500.500.700
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Sarcomeres".
Below are MeSH descriptors whose meaning is more specific than "Sarcomeres".
This graph shows the total number of publications written about "Sarcomeres" by people in this website by year, and whether "Sarcomeres" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2006 | 1 | 0 | 1 |
2017 | 1 | 2 | 3 |
2018 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Sarcomeres" by people in Profiles.
-
Prevalence, pathological mechanisms, and genetic basis of limb-girdle muscular dystrophies: A review. J Cell Physiol. 2019 06; 234(6):7874-7884.
-
Intrinsic mitral valve alterations in hypertrophic cardiomyopathy sarcomere mutation carriers. Eur Heart J Cardiovasc Imaging. 2018 10 01; 19(10):1109-1116.
-
Complex roads from genotype to phenotype in dilated cardiomyopathy: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology. Cardiovasc Res. 2018 08 01; 114(10):1287-1303.
-
Differential Sarcomere and Electrophysiological Maturation of Human iPSC-Derived Cardiac Myocytes in Monolayer vs. Aggregation-Based Differentiation Protocols. Int J Mol Sci. 2017 Jun 01; 18(6).
-
Widespread Down-Regulation of Cardiac Mitochondrial and Sarcomeric Genes in Patients With Sepsis. Crit Care Med. 2017 03; 45(3):407-414.
-
The Design of the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Trial. Am Heart J. 2017 May; 187:145-155.
-
Activin A inhibits organization of sarcomeric proteins in cardiomyocytes induced by leukemia inhibitory factor. J Mol Cell Cardiol. 2006 Oct; 41(4):689-97.